RecruitingNot ApplicableNCT02057783
Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
Comparison of Standard Treatment by Continuous Positive Airway Pressure (CPAP) and CPAP Combined to a Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension: RAP Randomized Controlled Trial
Sponsor
AGIR à Dom
Enrollment
100 participants
Start Date
Mar 26, 2015
Study Type
INTERVENTIONAL
Conditions
Summary
Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria3
- Patient with an obstructive sleep apnea (apnea-hypopnea index \> or equal to 15)
- Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents
- Ambulatory patient
Exclusion Criteria3
- Acute hepatic failure, biliary cirrhosis, cholestasis
- Acute hypertension (SBP\>= 180 mmHg and/or DBP \>= 110 mmHg)
- Contraindication to CPAP treatment
Interventions
OTHERPhysical activity
Physical activity will carry out 3 times per week during 12 weeks for intervention arm
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02057783
Related Trials
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
NCT062463961 location
Comorbidities Resolution After MGB Surgery and Change in Body Composition
NCT060156201 location
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
NCT060891611 location
Baroloop Multicenter Trial (Baroloop MCT)
NCT065189154 locations
Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA Overlap Syndrome (CO-OS)
NCT0595856315 locations